Eviagenics Closes on $1.77M
Paris-based biotech company Eviagenics has closed on 1.3 million euros ($1.77 million) in Series A financing. Emertec Management, CEA Investissement and CapDecisif Management provided the financing. Eviagenics is developing technology to create new products and improve manufacturing processes for the chemical and pharmaceutical industry.
9 February 2011•2 mins read
